Batch to Flow: Recent Advances in Continuous Flow Architectures for the Sustainable Synthesis of Heterocyclic APIs
Main Article Content
Abstract
The pharmaceutical industry is also under the decisive transition of the traditional processing batch system into the continuous manufacturing process production in terms of the growing necessity of safety, sustainability, and intensification of the process. This concise review addresses the advancements of the recent concurrent development of continuous flow architecture of sustainable synthesis of heterocyclic active pharmaceutical ingredient (API), the structural framework of the majority of the small-molecules drugs which are used today. The fundamental differences between batch and flow processing have been discussed where the principal concern is excellent heat and mass exchange, precision in the kinetic control, and high safety since less reactive inventory is utilized and scalability through naturally numbering-up methods. The review systematically surveys key platforms in reactors including micro- and meso-flow reactors, tubular and packed-bed reactors, multiphase reactors and as well as modular telescoped assemblies and parallels the principles of design of said assemblies with specific heterocyclic transformation. Environmental benefits of flow-based synthesis are measured by such types of sustainability measures as process mass intensity (PMI), reduction of E-factor, solvent reduction, energy efficiency, and the life cycle assessment (LCA) processes. The production of such technologies has an industrial relevance as exemplified by the representative case studies of nitrogen-, sulfur-, and oxygen-bearing heterocycles, and marketed APIs which are produced under constant-condition settings. Furthermore, automated catalysts that include process analytical technology (PAT), automations, machine learning-assisted optimization, photochemical and electrochemical flow reactors, in-vitro and in-vivo integrated catalytic and biocatalytic systems are listed as catalysts of the future manufacturing. The overall picture of this review is that continuous flow chemistry is an innovative and future-proof system through which heterocyclic APIs can be made in an efficient, safe, environmentally friendly way, leading to the bridges between the laboratory and the manufacturing of quality-by-design and regulatory-compliant product interpretation.